Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2024
Crispr-mediated genome editing reveals a preponderance of non-oncogene addictions as targetable vulnerabilities in pleural mesothelioma
Duo Xu, Shun-Qing Liang, Min Su, et al.
EMBO Molecular Medicine
|
July 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma
Duo Xu, Yanyun Gao, Shengchen Liu, et al.
Molecular Oncology
|
August 13, 2014
Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress
Ilya N Kotov, Ellen Siebring-van Olst, Philip A Knobel, et al.
Ebiomedicine
|
November 5, 2021
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
Limei Wang, Haitang Yang, Patrick Dorn, et al.
Respiratory Research
|
March 25, 2025
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices
Melanie Brügger, Carlos Machahua, Trix Zumkehr, et al.
Theranostics
|
May 13, 2022
Multi-scale integrative analyses identify THBS2<sup>+</sup> cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma
Haitang Yang, Beibei Sun, Liwen Fan, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 18, 2022
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
Zhang Yang, Shun-Qing Liang, Liang Zhao, et al.
Cell Death & Disease
|
April 16, 2021
Malignant pleural mesothelioma co-opts BCL-X<sub>L</sub> and autophagy to escape apoptosis
Duo Xu, Shun-Qing Liang, Zhang Yang, et al.
Cells
|
April 25, 2025
Pro-Inflammatory Properties of Salivary Gland-Derived Fibroblasts-Implications in Sjögren's Disease
Matthias Brunner, Daniel Guggisberg, Marco Sprecher, et al.
Cancer Research
|
March 9, 2021
CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for <i>FGFR1</i>-Amplified Lung Cancer
Zhang Yang, Shun-Qing Liang, Haitang Yang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2024
Crispr-mediated genome editing reveals a preponderance of non-oncogene addictions as targetable vulnerabilities in pleural mesothelioma
Duo Xu, Shun-Qing Liang, Min Su, et al.
EMBO Molecular Medicine
|
July 24, 2025
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma
Duo Xu, Yanyun Gao, Shengchen Liu, et al.
Molecular Oncology
|
August 13, 2014
Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress
Ilya N Kotov, Ellen Siebring-van Olst, Philip A Knobel, et al.
Ebiomedicine
|
November 5, 2021
Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
Limei Wang, Haitang Yang, Patrick Dorn, et al.
Respiratory Research
|
March 25, 2025
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices
Melanie Brügger, Carlos Machahua, Trix Zumkehr, et al.
Theranostics
|
May 13, 2022
Multi-scale integrative analyses identify THBS2<sup>+</sup> cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma
Haitang Yang, Beibei Sun, Liwen Fan, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 18, 2022
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
Zhang Yang, Shun-Qing Liang, Liang Zhao, et al.
Cell Death & Disease
|
April 16, 2021
Malignant pleural mesothelioma co-opts BCL-X<sub>L</sub> and autophagy to escape apoptosis
Duo Xu, Shun-Qing Liang, Zhang Yang, et al.
Cells
|
April 25, 2025
Pro-Inflammatory Properties of Salivary Gland-Derived Fibroblasts-Implications in Sjögren's Disease
Matthias Brunner, Daniel Guggisberg, Marco Sprecher, et al.
Cancer Research
|
March 9, 2021
CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for <i>FGFR1</i>-Amplified Lung Cancer
Zhang Yang, Shun-Qing Liang, Haitang Yang, et al.
Page
of 6